Preliminary Results of Foundation-Supported Project Presented at Group Meeting

Jun 02, 2015

Preliminary Results of Foundation-Supported Project Presented at Group Meeting

Omar Aljitawi, MD, of the University of Kansas Cancer Center, has been researching a method to shorten the duration of neutropenia following stem cell transplantation, a standard-of-care procedure which accompanies high-dose chemotherapy for treatment of multiple blood cancers. Neutropenia invariably occurs following high-dose chemotherapy and resolves when the newly infused hematopoietic stem cells home to […]

Read More →